CAIHL read · Jun 11, 2026
Early Alzheimer's detection is now a treatment decision
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
patient
Patients, families, and care partners are the primary users of this AI.
Hosting
public
Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.
Interests
patient-aligned
Interest structure prioritizes patients. Operates on a philanthropic, public-service, or advocacy footing.
Agency
expanding
Expands patient capabilities, supports their questions, increases their ability to act on their own values across and beyond health systems.
Editor's CAIHL read
One-sentence synthesis
Reframing the screening decision around treatment availability; expanding patient agency in the interpretive layer.
In the scan
How this item appeared in the daily scan
Editor's note: Once the treatment option becomes meaningful, the screening question stops being optional. The same logic runs through the AI early-detection literature: the value of the test is decided by the treatment available downstream of the result.
Summary: KevinMD: Clinician-essay reframing early Alzheimer's detection from 'is the test worth taking' to 'is the treatment available worth knowing about' — the locus of the decision has moved one step upstream.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.